Simiao Wan and its ingredients alleviate type 2 diabetes mellitus via IRS1/AKT2/FOXO1/GLUT2 signaling

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a metabolic disease. Simiao Wan (SMW) is a commonly used clinical drug for hyperuricemia treatment. SMW has been confirmed to improve insulin resistance and is expected to be a novel hypoglycemic agent. However, the hypoglycemic bioactive ingredients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Ting, Xu, Wen-Jie, Hu, Yan-Nan, Luo, Zhen-Ye, He, Wen, Liu, Chang-Shun, Tan, Xiao-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868910/
https://www.ncbi.nlm.nih.gov/pubmed/36698459
http://dx.doi.org/10.3389/fnut.2022.1012961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868910/
https://www.ncbi.nlm.nih.gov/pubmed/36698459
http://dx.doi.org/10.3389/fnut.2022.1012961

Ejemplares similares